{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02824393",
      "OrgStudyIdInfo": {
        "OrgStudyId": "TUBITAK-1001-215S612"
      },
      "Organization": {
        "OrgFullName": "Celal Bayar University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria",
      "OfficialTitle": "Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria"
    },
    "StatusModule": {
      "StatusVerifiedDate": "July 2018",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "March 3, 2017",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "May 15, 2018",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "July 15, 2018",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "June 29, 2016",
      "StudyFirstSubmitQCDate": "July 1, 2016",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "July 6, 2016",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "July 17, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "July 18, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Cengiz Kırmaz",
        "ResponsiblePartyInvestigatorTitle": "Professor Doctor (MD)",
        "ResponsiblePartyInvestigatorAffiliation": "Celal Bayar University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Celal Bayar University",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "The Scientific and Technological Research Council of Turkey",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Acıbadem Labcell",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The aim of this study is to determine whether autologous adipose tissue derived Mesenchymal Stem Cells of treatment for chronic autoimmune urticaria is safe and effective.",
      "DetailedDescription": "Chronic urticaria is a distressful disease, which negatively affects the quality of life. Pathogenesis isn't exactly clear, treatment is relatively palliative and results are usually suboptimal. 30-40% of the patients have autoimmune origin. Patients are forced to use immunosuppressive treatments which have systemic effects. Some of the treatments have effects as severe as the disease itself.\n\nMesenchymal stem cells (MSCs) are the most common used cells in clinical trials. These cells can provide efficient immunosuppression in severe conditions like immunosuppressive resistant Graft versus Host Disease. With this study at the first time and quite a different approach from conventional treatment, it will be tried an experimental treatment that used in the MSCs for the chronic autoimmune urticaria patients without of definitive treatment."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Urticaria",
          "Autoimmune Diseases",
          "Immune System Diseases",
          "Skin Diseases"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Mesenchymal stem cell",
          "Chronic autoimmune urticaria"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Early Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Factorial Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "10",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Mesenchymal stem cell",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Intravenous infusion of ex vivo cultured adipose tissue derived autologous mesenchymal stem cells, twice at two week intervals in total 1x10/6 cells/kg.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Autologous mesenchymal stem cell"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control patients",
            "ArmGroupType": "No Intervention",
            "ArmGroupDescription": "The patients who treated with the conventional therapy for urticaria, but not treat with mesenchymal stem cell."
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Autologous mesenchymal stem cell",
            "InterventionDescription": "Intravenous infusion of ex vivo cultured adipose tissue derived autologous mesenchymal stem cells, twice at two week intervals in total 1x10/6 cells/kg.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mesenchymal stem cell"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Autologous adipose tissue derived mesenchymal stem cell"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Change from baseline in weekly urticaria activity scores.",
            "PrimaryOutcomeDescription": "The weekly urticaria activity scores will be assessed according to European Academy of Allergy and Clinical Immunology (EAACI) / Global Allergy and Asthma European Network (GALEN) guidelines.",
            "PrimaryOutcomeTimeFrame": "6 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Follow-up of the mesenchymal stem cell treatment-related side effects according to World Health Organisation (WHO) Toxicity Grading Scale for Determining The Severity of Adverse Events.",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "The changes in the ratios of peripheral blood cluster of differentiation 4 (CD4) T cell subsets.",
            "SecondaryOutcomeTimeFrame": "6 months"
          },
          {
            "SecondaryOutcomeMeasure": "The changes in ratios of peripheral blood inflammatory and anti-inflammatory cytokines.",
            "SecondaryOutcomeTimeFrame": "6 months"
          },
          {
            "SecondaryOutcomeMeasure": "The changes in the levels of peripheral blood anti-FcεRI autoantibody",
            "SecondaryOutcomeTimeFrame": "6 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients diagnosed with chronic autoimmune urticaria (at least six months before)\nPatients who have >20 and over of urticaria activity score [according to European Academy of Allergy and Clinical Immunology (EAACI) / Global Allergy and Asthma European Network (GALEN) guidelines].\nPatients who capable of own daily findings record.\nPatients who could not be controlled despite the use of a treatment agent in the fourth step for 3 months (according to EAACI / GALEN guidelines).\n\nExclusion Criteria:\n\nPatients who have heart, liver or renal failure.\nPatients who have epilepsy, cerebrovascular or ischemic attack.\nPatients who have atopic dermatitis or another underlying itchy skin disease.\nPatients who have parasitic infection.\nPatients who have antibiotic allergy.\nHistory of malignancy.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Alper Tunga Özdemir, PhD",
            "OverallOfficialAffiliation": "Ege University, Institute of Health Sciences, Department of Stem Cell, Izmir/TURKEY",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Ercüment Ovalı, Prof. Dr.",
            "OverallOfficialAffiliation": "Acıbadem Labcell, Istanbul/TURKEY",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Celal Bayar University, Medical School",
            "LocationCity": "Manisa",
            "LocationCountry": "Turkey"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Yes"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000014581",
            "ConditionMeshTerm": "Urticaria"
          },
          {
            "ConditionMeshId": "D000012871",
            "ConditionMeshTerm": "Skin Diseases"
          },
          {
            "ConditionMeshId": "D000080223",
            "ConditionMeshTerm": "Chronic Urticaria"
          },
          {
            "ConditionMeshId": "D000001327",
            "ConditionMeshTerm": "Autoimmune Diseases"
          },
          {
            "ConditionMeshId": "D000007154",
            "ConditionMeshTerm": "Immune System Diseases"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000017445",
            "ConditionAncestorTerm": "Skin Diseases, Vascular"
          },
          {
            "ConditionAncestorId": "D000006969",
            "ConditionAncestorTerm": "Hypersensitivity, Immediate"
          },
          {
            "ConditionAncestorId": "D000006967",
            "ConditionAncestorTerm": "Hypersensitivity"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M3781",
            "ConditionBrowseLeafName": "Autoimmune Diseases",
            "ConditionBrowseLeafAsFound": "Autoimmune Diseases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14826",
            "ConditionBrowseLeafName": "Skin Diseases",
            "ConditionBrowseLeafAsFound": "Skin Diseases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M16482",
            "ConditionBrowseLeafName": "Urticaria",
            "ConditionBrowseLeafAsFound": "Urticaria",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafAsFound": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M2129",
            "ConditionBrowseLeafName": "Chronic Urticaria",
            "ConditionBrowseLeafAsFound": "Chronic Autoimmune Urticaria",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9170",
            "ConditionBrowseLeafName": "Hypersensitivity",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9172",
            "ConditionBrowseLeafName": "Hypersensitivity, Immediate",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    }
  }
}